Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 21, 2014; 20(19): 5826-5838
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5826
Table 1 Clinical characteristics of individuals enrolled in the study n (%)
Clinical characteristicsHCC numberControl number
Age at baseline, years
≥ 6020 (32.3)6 (27.3)
< 6042 (67.7)16 (72.7)
Median5551
Range29-7620-72
Sex
Male53 (85.5)11 (50.0)
Female9 (14.5)11 (50.0)
KPS score
> 8031 (50.0)22 (100.0)
60-8031 (50.0)0 (0.0)
Hepatitis infection
HBV positive59 (95.2)7 (31.2)
HBV negative3 (4.8)15 (68.2)
Tumor size (cm)NA
≤ 3.021 (33.9)
> 3.041 (66.1)
Primary fociNA
Single54 (87.1)
Multiple8 (12.9)
Carcinoma cell embolusNA
Yes1 (1.6)
No61 (98.4)
AJCC stage at enrollmentNA
Early (stage 1 + 2)55 (88.7)
Late (stage 3 + 4)7 (11.3)